By month three, weight loss may become more visible
Our patients who have limited physical function at baseline, they can actually expect to have the most benefits, Alpana Shukla, MD, FTOS, associate professor and director of clinical research in the division of endocrinology, diabetes and metabolism at the Comprehensive Weight Control Center at Weill Cornell Medicine, said during a presentation
Molecular connectomics reveals a glucagon-like peptide 1-sensitive neural circuit for satiety
Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks
On its latest earnings call, the company said it was aiming to restock the U.S